All Sauce from Weekly Gravy:

The bad news? COVID-19 may be around for a long, long time. The good news? Even if it does, new research suggests it could very well end up being just another mild illness, bringing with it inconvenience and discomfort, but rarely hospitalization or death. Why? The theory is rooted in the epidemiology patterns previously followed by four other coronaviruses. All have been in circulation for a very long time. In fact, they’re endemic, which means that most people get infected and develop immunity during childhood that protects against serious illness (although not reinfection) as adults. And that trajectory led a team of investigators to model what might ultimately happen in the future if most people were similarly exposed to the new coronavirus during childhood. “In the vast majority of cases, the endemic human coronaviruses [HCoVs] cause nothing more than a common cold, [meaning an] upper respiratory tract infection,” said study author Jennie Lavine, a postdoctoral researcher in the department of biology at Emory University in Atlanta. About 15% of adult common colds are believed to be attributable to HCoVs, she added. “They sometimes lead to lower respiratory tract infections, particularly in very young children and the elderly,” Lavine noted. Only in rare cases, among particularly vulnerable populations, do they trigger more serious illness. “It seems likely that COVID-19 will end up playing out this way,”…  read on >  read on >

Mindfulness is all the rage when it comes to boosting mental health, but new research suggests that it may not help everyone equally. Practicing mindfulness meditation — which involves paying close attention to what you are feeling in the moment — may be better than doing nothing at all to improve anxiety, depression or lower stress, but it is not a cure-all and may not be any better than other practices aimed at improving mental health and well-being, such as exercise, said study author Julieta Galante. She’s a research associate in the department of psychiatry at the University of Cambridge in the United Kingdom. To arrive at that conclusion, Galante and her colleagues reviewed data from 136 studies on mindfulness training for stress, anxiety, depression and overall well-being that took place in non-medical community settings (such as workplaces, universities, community centers or private studios). These trials included more than 11,600 participants, aged 18 to 73, from 29 countries. Mindfulness reduced anxiety, depression and stress, and increased well-being when compared to doing nothing, the study showed. But in more than one in 20 studies in the analysis, mindfulness meditation didn’t produce any benefits. Not all mindfulness programs are created equally, Galante noted. Differences in how they are taught, where they are taught, who teaches them, and who they are targeted to likely plays a big role…  read on >  read on >

Folks who’ve gotten through a COVID-19 infection might naturally question whether they need to get a coronavirus vaccination when their turn comes. Experts say they really need the shot anyway, because even after having COVID they might be vulnerable to reinfection. “We’re encouraging people if they meet the other criteria to get immunized because we don’t know how long either natural immunity or vaccine immunity lasts,” said Dr. Chris Beyrer, a professor of public health and human rights at Johns Hopkins Bloomberg School of Public Health in Baltimore. All previously known coronaviruses are notorious for promoting short-lived immunity in humans, he said. “Unfortunately, with other coronaviruses typically the immunity you have — like if you get a common cold coronavirus — usually only lasts about a year and a half to two years and then you’re vulnerable again,” Beyrer said. This is because the body uses a relatively simple strategy to fight off common cold coronaviruses, and this strategy does not appear to make a lasting impression on immune system memory, said Dr. Greg Poland, director of the Vaccine Research Group at the Mayo Clinic in Rochester, Minn. As such, he said there’s a chance people who had asymptomatic or mild cases of COVID-19 did not build up any lasting immunity. “Particularly for people who have milder cases, it may be that they don’t have…  read on >  read on >

The bad news? COVID-19 may be around for a long, long time. The good news? Even if it does, new research suggests it could very well end up being just another mild illness, bringing with it inconvenience and discomfort, but rarely hospitalization or death. Why? The theory is rooted in the epidemiology patterns previously followed by four other coronaviruses. All have been in circulation for a very long time. In fact, they’re endemic, which means that most people get infected and develop immunity during childhood that protects against serious illness (although not reinfection) as adults. And that trajectory led a team of investigators to model what might ultimately happen in the future if most people were similarly exposed to the new coronavirus during childhood. “In the vast majority of cases, the endemic human coronaviruses [HCoVs] cause nothing more than a common cold, [meaning an] upper respiratory tract infection,” said study author Jennie Lavine, a postdoctoral researcher in the department of biology at Emory University in Atlanta. About 15% of adult common colds are believed to be attributable to HCoVs, she added. “They sometimes lead to lower respiratory tract infections, particularly in very young children and the elderly,” Lavine noted. Only in rare cases, among particularly vulnerable populations, do they trigger more serious illness. “It seems likely that COVID-19 will end up playing out this way,”…  read on >  read on >

What makes a marathoner great? New research pinpoints the physical attributes of top marathon runners, and could help others improve their marathon performance. Elite male distance runners were asked to run on treadmills at a range of speeds and also on an outdoor track at a speed of 13.1 miles per hour, comparable to completing a marathon in two hours. While the marathoners ran, researchers measured their heart rate, oxygen consumption and levels of lactic acid in the blood, to determine efficiency of oxygen use during exercise. The study also assessed the marathoners’ running force, stride length and body composition. Only seven of the 16 participants achieved a VO2 steady state (stable oxygen consumption) when running at the two-hour marathon pace. That highlights how extremely difficult it is to complete a marathon in under two hours, the researchers said. Overall, the athletes maintained a VO2 of 67 milliliters per kilogram of body weight per minute (ml/kg/min) at just over 13 mph, about twice as much as the average person can achieve when exercising at their maximum. Also, the marathoners’ lactic acid threshold — the speed at which it builds up in the body — occurred at a very high fraction of their VO2 max. Lactic acid is produced by the body as it turns food into energy during exercise; in the muscles it’s related to…  read on >  read on >

Folks who’ve gotten through a COVID-19 infection might naturally question whether they need to get a coronavirus vaccination when their turn comes. Experts say they really need the shot anyway, because even after having COVID they might be vulnerable to reinfection. “We’re encouraging people if they meet the other criteria to get immunized because we don’t know how long either natural immunity or vaccine immunity lasts,” said Dr. Chris Beyrer, a professor of public health and human rights at Johns Hopkins Bloomberg School of Public Health in Baltimore. All previously known coronaviruses are notorious for promoting short-lived immunity in humans, he said. “Unfortunately, with other coronaviruses typically the immunity you have — like if you get a common cold coronavirus — usually only lasts about a year and a half to two years and then you’re vulnerable again,” Beyrer said. This is because the body uses a relatively simple strategy to fight off common cold coronaviruses, and this strategy does not appear to make a lasting impression on immune system memory, said Dr. Greg Poland, director of the Vaccine Research Group at the Mayo Clinic in Rochester, Minn. As such, he said there’s a chance people who had asymptomatic or mild cases of COVID-19 did not build up any lasting immunity. “Particularly for people who have milder cases, it may be that they don’t have…  read on >  read on >

The bad news? COVID-19 may be around for a long, long time. The good news? Even if it does, new research suggests it could very well end up being just another mild illness, bringing with it inconvenience and discomfort, but rarely hospitalization or death. Why? The theory is rooted in the epidemiology patterns previously followed by four other coronaviruses. All have been in circulation for a very long time. In fact, they’re endemic, which means that most people get infected and develop immunity during childhood that protects against serious illness (although not reinfection) as adults. And that trajectory led a team of investigators to model what might ultimately happen in the future if most people were similarly exposed to the new coronavirus during childhood. “In the vast majority of cases, the endemic human coronaviruses [HCoVs] cause nothing more than a common cold, [meaning an] upper respiratory tract infection,” said study author Jennie Lavine, a postdoctoral researcher in the department of biology at Emory University in Atlanta. About 15% of adult common colds are believed to be attributable to HCoVs, she added. “They sometimes lead to lower respiratory tract infections, particularly in very young children and the elderly,” Lavine noted. Only in rare cases, among particularly vulnerable populations, do they trigger more serious illness. “It seems likely that COVID-19 will end up playing out this way,”…  read on >  read on >

What makes a marathoner great? New research pinpoints the physical attributes of top marathon runners, and could help others improve their marathon performance. Elite male distance runners were asked to run on treadmills at a range of speeds and also on an outdoor track at a speed of 13.1 miles per hour, comparable to completing a marathon in two hours. While the marathoners ran, researchers measured their heart rate, oxygen consumption and levels of lactic acid in the blood, to determine efficiency of oxygen use during exercise. The study also assessed the marathoners’ running force, stride length and body composition. Only seven of the 16 participants achieved a VO2 steady state (stable oxygen consumption) when running at the two-hour marathon pace. That highlights how extremely difficult it is to complete a marathon in under two hours, the researchers said. Overall, the athletes maintained a VO2 of 67 milliliters per kilogram of body weight per minute (ml/kg/min) at just over 13 mph, about twice as much as the average person can achieve when exercising at their maximum. Also, the marathoners’ lactic acid threshold — the speed at which it builds up in the body — occurred at a very high fraction of their VO2 max. Lactic acid is produced by the body as it turns food into energy during exercise; in the muscles it’s related to…  read on >  read on >

Biomarkers in sperm may help identify men at risk of fathering children with autism, researchers say. For the study, investigators examined sperm epigenetics — the molecular processes that affect gene expression — in 13 men who fathered sons with autism and 13 who had children without the disorder. The American and Spanish researchers focused specifically on DNA methylation, a chemical modification that can turn genes on or off. “We can now potentially use this to assess whether a man is going to pass autism on to his children,” said study co-author Michael Skinner, professor of biological sciences at Washington State University, in Pullman, Wash. “It is also a major step toward identifying what factors might promote autism,” he said in a university news release. The study found 805 different DNA methylation regions that could be epigenetic biomarkers, indicating men more likely to have children with autism. To test their findings about these biomarkers, the researchers used sperm samples from 18 men to see if they could identify those with and without children with autism. The results were 90% accurate, according to the study. But Skinner and his colleagues said more research must be done before this approach can be used in clinical practice. The team is now working on a larger study involving 100 men. “We found out years ago that environmental factors can alter…  read on >  read on >

Many Americans most affected by the COVID-19 pandemic don’t believe that racism is associated with poorer health, a nationwide poll shows. The ongoing poll of more than 4,000 lower- and middle-income Americans focuses on communities of color. “It really struck us that — despite the virus’s spread across the country to all types of communities — there’s not a consensus view on the effects of systemic racism,” said lead author Katherine Grace Carman, a senior economist at RAND Corporation. RAND is conducting the poll, with support from the Robert Wood Johnson Foundation. “Respondents see the impact of low incomes and living in a rural community on a person’s health, but race isn’t viewed with the same gravity,” she said in a Robert Wood Johnson news release.Just over 42% of respondents say systemic racism is one of the main reasons people of color have poorer health. About one-third disagree, and about a quarter are neutral. Black respondents are much more likely (69.4%) than white ones (33.2%) to believe that systemic racism affects the health of people of color, according to the poll. Overall, pollsters found a slight increase in respondents’ willingness to risk their own health to return to pre-pandemic “normal.” But respondents who are Black or Hispanic are more likely (68.5%) to be cautious about taking health risks to move about freely than white respondents…  read on >  read on >